0001179110-20-007163.txt : 20200610 0001179110-20-007163.hdr.sgml : 20200610 20200610075402 ACCESSION NUMBER: 0001179110-20-007163 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200609 FILED AS OF DATE: 20200610 DATE AS OF CHANGE: 20200610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marucci Anthony S CENTRAL INDEX KEY: 0001429933 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 20953520 MAIL ADDRESS: STREET 1: 66 COLD HILL DRIVE CITY: MENDAHM STATE: NJ ZIP: 07945 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml FORM 4 - X0306 4 2020-06-09 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001429933 Marucci Anthony S C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD HAMPTON NJ 08827 1 1 0 0 President & CEO Common Stock, par value $0.001 per share 2020-06-09 4 P 0 15000 3.06 A 19438 D Includes 1,103 shares of Common Stock acquired under the Company's 2004 Employee Stock Purchase Plan. /s/ Samuel B. Martin, attorney in fact for Anthony S. Marucci 2020-06-10